To comprehensively determine the spectrum of ALK alterations in neuroblastomas at diagnosis and at relapse, we retrospectively collected data on ALK mutations and/or amplifications from tumors of 943 neuroblastoma patients. Here, ALK is linked to neuroblastoma.